James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 84,874 shares at $17.46 ($1.4M) on 2021-12-27, disclosed to the SEC on 2021-12-27.
Open-market sale of $1.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.28 | 23,390 | $381K | 27.0% |
| 2 | $16.28 | 23,390 | $381K | 27.0% |
| 3 | $16.90 | 12,610 | $213K | 15.1% |
| 4 | $16.90 | 12,610 | $213K | 15.1% |
| 5 | $17.46 | 6,437 | $112K | 8.0% |
| 6 | $17.46 | 6,437 |
| $112K |
| 8.0% |
| Total | $16.64 avg | 84,874 | $1.4M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |